Table 1.
Characteristics of study population.
| Clinical Characteristic (N=381) | N (%) |
|---|---|
|
| |
| Age at Diagnosis, mean (SD) | 61 (11) |
|
| |
| Age at Diagnosis <50 | |
| Yes | 50 (13) |
| No | 331 (87) |
|
| |
| Race | |
| Caucasian | 265 (70) |
| African-American | 34 (9) |
| Hispanic | 66 (17) |
| Asian | 14 (4) |
| Native American | 2 (1) |
|
| |
| BMI | |
| Underweight | 3 (1) |
| Normal Weight | 58 (15) |
| Overweight | 79 (21) |
| Obese | 241 (63) |
|
| |
| FIGO Stage | |
| I | 266 (70) |
| II | 25 (7) |
| III | 55 (14) |
| IV | 34 (9) |
| Unknown | 1 (0) |
|
| |
| FIGO Grade1 | |
| 1 | 35 (9) |
| 2 | 215 (56) |
| 3 | 131 (34) |
|
| |
| Histology | |
| Endometrioid | 289 (76) |
| Serous | 26 (7) |
| Clear Cell | 10 (3) |
| Mixed | 44 (12) |
| Carcinosarcoma | 7 (2) |
| Undifferentiated | 5 (1) |
1
Non-endometrioid carcinomas were designated as grade 3.